T-group (topology)
180.1.1 Acid phosphatase/Vanadium-dependent haloperoxidase
Ligands and drugs
717
Member domains
108
with ligand contacts (≤ 4 Å)
15.1% of members
86
with DrugDomain annotations
12.0% of members
49
with a DrugBank compound
6.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 180.1.1 belongs to X-group 180 Acid phosphatase/Vanadium-dependent haloperoxidase, which has 12 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03570 | 144 | Tris-Hydroxymethyl-Methyl-Ammonium | 6 |
| DB07780 | FPP | Farnesyl diphosphate | 4 |
| DB15878 | MOO | Molybdate | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 34 |
| VO4 | VANADATE ION | 32 |
| NAmetal | SODIUM ION | 20 |
| BR | BROMIDE ION | 10 |
| CL | CHLORIDE ION | 7 |
| 144 | TRIS-HYDROXYMETHYL-METHYL-AMMONIUM | 6 |
| WO4 | TUNGSTATE(VI)ION | 6 |
| FPP | FARNESYL DIPHOSPHATE | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| MOO | MOLYBDATE ION | 3 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 3 |
| 46E | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl tetradecanoate | 2 |
| AZI | AZIDE ION | 2 |
| LBN | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | 2 |
| LPP | 2-(HEXADECANOYLOXY)-1-[(PHOSPHONOOXY)METHYL]ETHYL HEXADECANOATE | 2 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 2 |
| PER | PEROXIDE ION | 2 |
| PT5 | [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate | 2 |
| CPL | 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 1 |
| ILW | 1,3,5-trimethoxybenzene | 1 |